TTY Biopharm Company Limited (TPEX:4105)
Taiwan · Delayed Price · Currency is TWD 82.20
+0.90 (1.11%)
Nov 10, 2026, 1:30 PM CST
TTY Biopharm Company Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,785 | 2,521 | 2,773 | 2,621 | 2,357 | 2,222 |
Short-Term Investments | 12.99 | 467.74 | 309.02 | 195.54 | 326.86 | 372.65 |
Cash & Short-Term Investments | 2,798 | 2,989 | 3,082 | 2,817 | 2,684 | 2,595 |
Cash Growth | -7.93% | -3.02% | 9.41% | 4.93% | 3.44% | 1.12% |
Accounts Receivable | 1,822 | 1,518 | 1,354 | 1,344 | 1,227 | 1,138 |
Other Receivables | 49.15 | 36.46 | 23.18 | 28.81 | 29.68 | 13.62 |
Receivables | 1,871 | 1,554 | 1,377 | 1,373 | 1,257 | 1,151 |
Inventory | 1,665 | 1,389 | 1,270 | 1,096 | 1,039 | 955.01 |
Prepaid Expenses | 57.73 | - | - | 79.02 | 49.89 | 46.96 |
Other Current Assets | 273.39 | 76.88 | 64.58 | 6.36 | 5.37 | 1.15 |
Total Current Assets | 6,665 | 6,009 | 5,793 | 5,370 | 5,035 | 4,749 |
Property, Plant & Equipment | 2,119 | 2,199 | 2,246 | 2,287 | 2,433 | 2,519 |
Long-Term Investments | 1,938 | 2,205 | 1,940 | 1,578 | 1,496 | 1,432 |
Goodwill | - | 247.9 | 247.9 | - | - | - |
Other Intangible Assets | 659.16 | 177.27 | 123.44 | 164.01 | 250.75 | 124.9 |
Long-Term Deferred Tax Assets | 65.8 | 65.8 | 58.52 | 48.71 | 47.1 | 63.72 |
Other Long-Term Assets | 795.16 | 444.8 | 453.25 | 426.94 | 337.89 | 407.19 |
Total Assets | 12,242 | 11,348 | 10,863 | 9,875 | 9,601 | 9,296 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 361.29 | 270.78 | 326.16 | 294.66 | 289.4 | 187.27 |
Short-Term Debt | 1,350 | 700 | 1,200 | 1,450 | 1,370 | 1,711 |
Current Portion of Long-Term Debt | 118.23 | 500 | 400 | - | 418.85 | 407.91 |
Current Portion of Leases | 8.64 | 8.35 | 0.93 | 5.86 | 3.92 | 7.62 |
Current Income Taxes Payable | 189.94 | 323.68 | 228.8 | 156.97 | 149.52 | 150.39 |
Current Unearned Revenue | 47.07 | 53.7 | 34.34 | 14.23 | 33.13 | 39.77 |
Other Current Liabilities | 783.58 | 783.33 | 672.18 | 662.02 | 652.62 | 547.55 |
Total Current Liabilities | 2,859 | 2,640 | 2,862 | 2,584 | 2,917 | 3,052 |
Long-Term Debt | 400 | - | 100 | 400 | 9.6 | 4.15 |
Long-Term Leases | 4.03 | 7.4 | 10.2 | 3.05 | 3.04 | 14.16 |
Pension & Post-Retirement Benefits | - | 17.01 | 17.54 | 27.4 | 40.81 | 52.6 |
Long-Term Deferred Tax Liabilities | 363.19 | 363.19 | 359.24 | 318.75 | 305.44 | 260.52 |
Other Long-Term Liabilities | 290.6 | 269.3 | 2.44 | 35.83 | 91.03 | 146.23 |
Total Liabilities | 3,917 | 3,297 | 3,352 | 3,369 | 3,367 | 3,529 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,487 | 2,487 | 2,487 | 2,487 | 2,487 | 2,487 |
Additional Paid-In Capital | 317.84 | 317.56 | 317.04 | 316.62 | 312.18 | 311.88 |
Retained Earnings | 4,664 | 4,427 | 3,888 | 3,182 | 2,925 | 2,568 |
Comprehensive Income & Other | -2.84 | 7.18 | 58.69 | -43.79 | -64.78 | -198.07 |
Total Common Equity | 7,465 | 7,238 | 6,750 | 5,941 | 5,658 | 5,168 |
Minority Interest | 860.41 | 812.93 | 760.49 | 564.8 | 574.86 | 599.38 |
Shareholders' Equity | 8,326 | 8,051 | 7,511 | 6,506 | 6,233 | 5,767 |
Total Liabilities & Equity | 12,242 | 11,348 | 10,863 | 9,875 | 9,601 | 9,296 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,881 | 1,216 | 1,711 | 1,859 | 1,805 | 2,145 |
Net Cash (Debt) | 917.18 | 1,773 | 1,371 | 957.65 | 878.78 | 450 |
Net Cash Growth | -10.51% | 29.36% | 43.11% | 8.97% | 95.28% | 6.52% |
Net Cash Per Share | 3.68 | 7.11 | 5.50 | 3.84 | 3.53 | 1.81 |
Filing Date Shares Outstanding | 248.12 | 248.65 | 248.65 | 248.65 | 248.65 | 248.65 |
Total Common Shares Outstanding | 248.12 | 248.65 | 248.65 | 248.65 | 248.65 | 248.65 |
Working Capital | 3,807 | 3,369 | 2,931 | 2,787 | 2,118 | 1,698 |
Book Value Per Share | 30.09 | 29.11 | 27.15 | 23.89 | 22.76 | 20.78 |
Tangible Book Value | 6,806 | 6,813 | 6,379 | 5,777 | 5,408 | 5,043 |
Tangible Book Value Per Share | 27.43 | 27.40 | 25.65 | 23.23 | 21.75 | 20.28 |
Land | - | 902.9 | 902.9 | 902.9 | 902.9 | 902.9 |
Buildings | - | 1,495 | 1,479 | 1,461 | 1,432 | 1,420 |
Machinery | - | 1,443 | 1,446 | 1,432 | 1,418 | 1,359 |
Construction In Progress | - | 71.53 | 0.59 | 8.95 | 77.09 | 95 |